Study of the No-touch Saphenous Vein Graft

Sponsor
Meshalkin Research Institute of Pathology of Circulation (Other)
Overall Status
Recruiting
CT.gov ID
NCT05757947
Collaborator
(none)
106
1
2
24
4.4

Study Details

Study Description

Brief Summary

Authors hypothesize that "no-touch" saphenous vein as I graft is superior over conventional "no-touch" saphenous vein as free graft in the incidence of graft patency.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Сoronary bypass surgery according to the I-graft method
  • Procedure: Сoronary bypass surgery by the method of free conduit
N/A

Detailed Description

A multicenter single blind prospective randomized superiority study is conducted. Our hypothesis is that there is difference in the incidence of "no-touch" saphenous vein graft patency using it as the conventional free graft (group C) and I graft (group I) for myocardial revascularization more than 25%. If there is truly difference between groups, then total 106 patients for both groups are required to be 90% sure that the upper limit of a one-sided 95% confidence interval would reveal a difference in favour of the "no-touch" saphenous vein I graft of 25%. The blinding process is applied to a patient, who is informed about received harvesting method of saphenous vein, but don't know the type of the graft cofiguration. The study was approved by Institutional Review Board. Depending on a type of the procedure, the patients are divided into two groups: conventional free graft (group C) 53 patients and I graft (group I) 53 patients. Randomization is conducted befor operation by using accidental sampling.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Multicenter Clinical Trial of Myocardial Revascularization Using I-conduit and No-touch Saphenous Vein Graft
Actual Study Start Date :
Dec 22, 2022
Anticipated Primary Completion Date :
Dec 22, 2023
Anticipated Study Completion Date :
Dec 22, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: "no-touch" saphenous vein as I-graft

Coronary bypass surgery according to the I-graft method. Proximal anastomosis to RIMA.

Procedure: Сoronary bypass surgery according to the I-graft method
Revascularization of the right coronary artery basin will be performed using "no-touch" SVG and the formation of an anastomosis of the stump of the right internal mammary artery and end-to-end saphenous vein graft.

Active Comparator: "no-touch" saphenous vein as conventional free graft

Coronary artery bypass grafting using the free conduit technique. Proximal anastomosis to aorta.

Procedure: Сoronary bypass surgery by the method of free conduit
Revascularization of the right coronary artery basin will be performed using "no-touch" SVG and anastomosis of the saphenous vein graft to aorta.

Outcome Measures

Primary Outcome Measures

  1. Patency of "no-touch" saphenous vein graft [12 months after surgery]

    Assessment of the patency of coronary shunts

Secondary Outcome Measures

  1. Recurrence of angina pectoris [6 and 12 months after after surgery]

    Estimated percentage of participants with symptomatic angina at 6 and 12 months after surgery

  2. MACE [6 and 12 months after after surgery]

    Estimated percentage of participants with major adverse cardiac events at 6 and 12 months post-surgery

  3. Complications of the conduit fence site [6 and 12 months after after surgery]

    Estimated percentage of participants with wound complications, development of wound infection, postoperative neurological complications at the sampling site at 6 and 12 months after surgery

  4. Survival rate [6 and 12 months after after surgery]

    Estimated percentage of participants who died at 6 and 12 months after surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with coronary artery disease requiring three-vessel myocardial revascularization

  • Patient consent to the study

Exclusion Criteria:
  • The diameter of the target arteries for conduits of the internal mammary arteries is less than 1 mm

  • Hemodynamically significant atherosclerosis of the subclavian arteries in the first segment

  • Stenosis of the right coronary artery less than 90%

  • Concomitant pathology requiring additional simultaneous surgical correction

  • Lack of HAV

  • COPD with FEV1 <60%

  • BMI >35

  • Prior heart surgery

  • Oncological diseases with a life expectancy of less than 5 years

  • ACS

  • CKD stage 4 and higher

  • The diameter of the SVG is less than 2 mm or its varicose expansion is more than 6 mm

  • CLTI IIb and more.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NMCR named after academician E.N. Meshalkin of the Ministry of Health of rhe Russian Novosibirsk Novosibirsk Region Russian Federation 630055

Sponsors and Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

Investigators

  • Principal Investigator: Dmitry Khvan, Ph.D., NMCR named after academician E.N. Meshalkin of the Ministry of Health of rhe Russian

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dmitry Khvan, candidate of medical sciences, senior researcher, сardiovascular surgeon of the NMRC named after academician E.N. Meshalkin of the Ministry of Health of Russian Federation, Meshalkin Research Institute of Pathology of Circulation
ClinicalTrials.gov Identifier:
NCT05757947
Other Study ID Numbers:
  • Super-SVG
First Posted:
Mar 7, 2023
Last Update Posted:
Mar 7, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dmitry Khvan, candidate of medical sciences, senior researcher, сardiovascular surgeon of the NMRC named after academician E.N. Meshalkin of the Ministry of Health of Russian Federation, Meshalkin Research Institute of Pathology of Circulation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2023